The COVID-19 vaccines currently in use are: Currently, children under 12 cannot have a COVID-19 vaccine however, this is likely to change over time as more data from clinical trials in younger age groups become available and when the Therapeutic Goods Administration (TGA) approves the use of the vaccine in younger age groups. In Australia, the Pfizer and Moderna vaccines have been approved for use in people aged 12 years and older. The vaccine was considered safe, with the majority of side effects considered mild to moderate and arising within the first 1 to 2 days, resolving shortly thereafter. The Pfizer vaccine data presented to the US Food and Drug Administration (FDA) showed the vaccine was 90% effective at preventing symptomatic COVID-19 infection in children aged 5–11 years. Studies from the USA and Israel have also assessed the effectiveness of the Pfizer vaccine in adolescents aged 12–18 years, with the Israeli study finding the vaccine to be 90% effective at preventing COVID-19 infection and the US study finding the vaccine to be 93% effective at preventing hospitalisations in this age group. A trial for the Moderna vaccine found the vaccine to be 92% effective in preventing symptomatic COVID-19 infection in adolescents aged 12–17 years. The Pfizer and Moderna vaccines are highly effective in adolescents, and the Pfizer vaccine is highly effective in children aged 5–11 years.Ī clinical trial for the Pfizer vaccine found the vaccine to be 100% effective at preventing COVID-19 infection in adolescents aged 12–15 years.
0 kommentar(er)
